CT-based Abdominal Adipose Tissue Area Changes in Patients Undergoing Adrenalectomy Due to Cushing’s Syndrome and Non-functioning Adenomas

 

 Buy Article Permissions and Reprints

Abstract

Background The majority of Cushing’s syndrome (CS) cases constitute patients with functional adrenal adenomas. In adrenal CS, visceral adipose tissue (VAT) area, VAT/subcutaneous adipose tissue (SAT), and VAT/total adipose tissue (TAT) ratios are expected to decrease in response to adrenalectomy, although no change is expected in non-functioning adrenal adenomas (NFA).

Objective To evaluate the changes in VAT, SAT, TAT areas and VAT/SAT, VAT/TAT ratios using computed tomography (CT) in patients who underwent adrenalectomy due to adenomas.

Methods Preoperative and postoperative CT of 32 patients (16 with CS and 16 with NFA) were retrospectively evaluated. The VAT, SAT, TAT areas were obtained from CT at the level of L1–2 intervertebral disc space, and the VAT/SAT, VAT/TAT ratios were calculated. The postoperative parameter changes in both groups were evaluated compared to the preoperative values. The level of statistical significance was considered as p<0.05.

Results The time interval between preoperative and postoperative CT measurements were 10.37 months (6–17) in CS and 9.75 months (7–15) in NFA groups (p=073). Preoperative CT indicated that the patients with CS had larger VAT and TAT areas (p=0.03, p=0.02) but SAT remained unchanged (p=0.08). However, postoperative CT revealed that there was no difference between the two groups in terms of VAT, TAT, and SAT areas (p=0.87, p=0.36, p=0.14). Postoperatively, in patients with CS, there was a decrease in VAT and TAT areas (p=0.01 for both) and VAT/SAT and VAT/TAT ratios (p=0.03, p=0.02) but SAT remained unchanged (p=0.10). In patients with NFA, no change was detected in the postoperative SAT, TAT, and VAT areas (p=0.12, p=0.40, p=0.99) or the VAT/SAT and VAT/TAT ratios (p=0.38, p=0.62).

Conclusions Adrenalectomy is an effective treatment method leading to a decrease in the VAT, TAT areas, and VAT/SAT and VAT/TAT ratios in patients with cortisol producing adrenocortical adenoma. Thus, CT facilitates quantitative demonstration of the changes while evaluating the response of these patients to treatment.

Publication History

Received: 17 March 2021
Received: 07 June 2021

Accepted: 07 July 2021

Article published online:
06 August 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Mosconi C, Vicennati V, Papadopoulos D. et al Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT Predictive Score. Am J Roentgenol 2017; 209: 122-129
  CrossrefPubMedGoogle Scholar
• 2 Comlekci A, Yener S, Ertilav S. et al Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010; 37: 40-46
  CrossrefPubMedGoogle Scholar
• 3 Elbanan MG, Javadi S, Ganeshan D. et al Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom Radiol (NY) 2020; 45: 905-916
  PubMed
• 4 Al-Thani H, El-Menyar A, Al-Sulaiti M. et al Adrenal mass in patients who underwent abdominal computed tomography examination. N Am J Med Sci 2015; 7: 212-219
  CrossrefPubMedGoogle Scholar
• 5 Kim J, Bae KH, Choi YK. et al Clinical characteristics for 348 patients with adrenal incidentaloma. Endocrinol Metab 2013; 28: 20-25
  CrossrefPubMedGoogle Scholar
• 6 Low G, Sahi K. Clinical and imaging overview of functional adrenal neoplasms. Int J Urol 2012; 19: 697-708
  CrossrefPubMedGoogle Scholar
• 7 Yener S. Metabolic and cardiovascular impact of non-functioning adrenal adenomas: a clinical dilemma. Eur J Intern Med 2013; 24: 520-524
  CrossrefPubMedGoogle Scholar
• 8 Barzon L, Sonino N, Fallo F. et al Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149: 273-285
  CrossrefPubMedGoogle Scholar
• 9 Mahmood E, Anastasopoulou C. Adrenal Adenoma. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing, 2021
• 10 Yener S, Baris M, Peker A. et al Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up. Clin Endocrinol (Oxf) 2017; 87: 425-432
  CrossrefPubMedGoogle Scholar
• 11 Rockall AG, Sohaib SA, Evans D. et al Computed tomography assessment of fat distribution in male and female patients with Cushing’s syndrome. Eur J Endocrinol 2003; 149: 561-567
  CrossrefPubMedGoogle Scholar
• 12 Carr DB, Utzschneider KM, Hull RL. et al Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094
  CrossrefPubMedGoogle Scholar
• 13 Goodpaster BH, Krishnaswami S, Harris TB. et al Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777-783
  CrossrefPubMedGoogle Scholar
• 14 Fassnacht M, Arlt W, Bancos I. et al Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2016; 175: 1-34
  CrossrefPubMedGoogle Scholar
• 15 Hong N, Lee J, Ku CR. et al Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism. Clin Endocrinol 2019; 90: 267-276
  CrossrefPubMedGoogle Scholar
• 16 Kuk JL, Church TS, Blair SN. et al Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome?. Diabetes Care 2006; 29: 679-684
  CrossrefPubMedGoogle Scholar
• 17 Yoshizumi T, Nakamura T, Yamane M. et al Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-286
  CrossrefPubMedGoogle Scholar
• 18 Pecori Giraldi F, Moro M, Cavagnini F. Study group on the hypothalamo-pituitary-adrenal axis of the Italian Society of Endocrinology. Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab 2003; 88: 1554-1558
  CrossrefPubMedGoogle Scholar
• 19 Zhou J, Zhang M, Bai X. et al Demographic characteristics, etiology, and comorbidities of patients with Cushing's syndrome: A 10-year retrospective study at a large general hospital in China. Int J Endocrinol 2019; 2019: 7159696
  CrossrefPubMedGoogle Scholar
• 20 Wengander S, Trimpou P, Papakokkinou E. et al The incidence of endogenous Cushing’s syndrome in the modern era. Clin Endocrinol (Oxf) 2019; 91: 263-270
  CrossrefPubMedGoogle Scholar
• 21 Giordano R, Marinazzo E, Berardelli R. et al Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol 2010; 162: 779-785
  CrossrefPubMedGoogle Scholar
• 22 Debono M, Prema A, Hughes TJ. et al Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma. J Clin Endocrinol Metab 2013; 98: 2383-2391
  CrossrefPubMedGoogle Scholar
• 23 Stratakis CA. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome). Endocr Dev 2008; 13: 117-132
  CrossrefPubMedGoogle Scholar
• 24 Larsson B, Svärdsudd K, Welin L. et al Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-1444
  CrossrefPubMedGoogle Scholar
• 25 Shahraki M, Shahraki T, Pourghasem GB. etal Central obesity and coronary heart disease risk factors in referral outpatients to zahedan cardiology clinic, iran. Int J High Risk Behav Addict 2012; 1: 79-83
  CrossrefPubMedGoogle Scholar
• 26 Borkan GA, Gerzof SG, Robbins AH. et al Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982; 36: 172-177
  CrossrefPubMedGoogle Scholar